| FDA notifications. Darunavir label has these changes. [Newspaper Article]
AIDS Alert 2008 Dec; 23(12):142-4.
Full Citation | Find Related Articles | | Wang L, Cai SR, Zhang CH, et al.
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model. [Journal Article]
Chin Med J (Engl) 2008 Nov 5; 121(21):2167-71.
Abstract | Full Citation | Find Related Articles | | Gao L, Yu DM
Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats. [Journal Article]
Chin Med J (Engl) 2008 Nov 5; 121(21):2129-33.
Abstract | Full Citation | Find Related Articles | | Narayanan RM, Chi LS, Choo LL, et al.
Renal outcomes in the ONTARGET study. [Comment, Letter]
Lancet 2008 Dec 13; 372(9655):2020; author reply 2020-1.
Full Citation | Publisher Full Text | Find Related Articles | | Wetzels JF
Renal outcomes in the ONTARGET study. [Comment, Letter]
Lancet 2008 Dec 13; 372(9655):2020; author reply 2020-1.
Full Citation | Publisher Full Text | Find Related Articles | | Gallieni M, Cozzolino M, Brancaccio D, et al.
Renal outcomes in the ONTARGET study. [Comment, Letter]
Lancet 2008 Dec 13; 372(9655):2019; author reply 2020-1.
Full Citation | Publisher Full Text | Find Related Articles | | Nonoguchi H, Nanami M, Hasuike Y, et al.
Renal outcomes in the ONTARGET study. [Comment, Letter]
Lancet 2008 Dec 13; 372(9655):2019-20; author reply 2020-1.
Full Citation | Publisher Full Text | Find Related Articles | | Barrios V, Escobar C, Echarri R
Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril. [Journal Article]
Vasc Health Risk Manag 2008; 4(4):847-53.
Abstract | Full Citation | | Richter B, Bandeira-Echtler E, Bergerhoff K, et al.
Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes. [Journal Article]
Vasc Health Risk Manag 2008; 4(4):753-68.
Abstract | Full Citation | | Green J, Feinglos M
New combination treatments in the management of diabetes: focus on sitagliptin-metformin. [Journal Article]
Vasc Health Risk Manag 2008; 4(4):743-51.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
